share_log

HC Wainwright & Co. Maintains Buy on Oncolytics Biotech, Lowers Price Target to $5

HC Wainwright & Co. Maintains Buy on Oncolytics Biotech, Lowers Price Target to $5

HC Wainwright & Co.维持对Oncolytics Biotech的买入,将目标价下调至5美元
Benzinga ·  2023/11/13 11:16

HC Wainwright & Co. analyst Patrick Trucchio maintains Oncolytics Biotech (NASDAQ:ONCY) with a Buy and lowers the price target from $15 to $5.

HC Wainwright & Co. 分析师帕特里克·特鲁基奥维持Oncolytics Biotech(纳斯达克股票代码:ONCY)的买入,并将目标股价从15美元下调至5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发